You searched for "ARN"

513 results found

Touching base with Peter Holland, CEO of the IAPB

For the upcoming Eye News Dec/Jan 2025, our co-editor, David Lockington, had the opportunity to sit down with the CEO of IAPB, Peter Holland. We’re really excited to share this interview with you, which delves into Peter’s fascinating career and...

Touching base with Peter Holland, CEO of the IAPB

For the upcoming Eye News Dec/Jan 2025, our co-editor, David Lockington, had the opportunity to sit down with the CEO of IAPB, Peter Holland. We’re really excited to share this interview with you, which delves into Peter’s fascinating career and...

What's trending Apr/May 2023

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Cyborgeye #flashlighteye #prostheticeye #BrianStanleyeye Brian Stanley is a California-based engineer, who lost his eye to retinoblastoma when he was six-years-old. A...

Conference Report: Uveitis-North West: Weaving a vision at the Whitworth Art Gallery

“It is necessary to mark the greater from the lesser truth: namely the larger and more liberal idea of nature from the comparatively narrow and confined; namely that which addresses itself to the imagination from that which is solely addressed...

COVID-19: Pete’s Bogus Journey

The author shares his personal experience of contracting coronavirus. I managed to body swerve COVID-19 for nine months. The Pfizer vaccine was being rolled out in my trust. I had my first inoculation booked in three weeks. I had survived...

An arm and a leg

“It cost me an arm and a leg.” – Mr B told me. An arm and a leg to be seen by the famous Russian eye surgeon who said that everybody can be spectacle-free. He took Mr B’s money (roughly...

MISS vs. conventional surgery

This was a prospective randomised parallel arm design study for 40 patients. Group 1 consisted of conventional strabismus surgery using the limbal approach and group 2 consisted of minimally invasive strabismus surgery (MISS). Mean age was 21.1±2.73 years for MISS...

Nepafenac punctal plugs after cataract surgery: a new alternative?

The nepafenac punctal plug delivery system (N-PPDS) is an experimental L-shaped plug made of nonbiodegradable, preservative-free medical-grade silicone. It can deliver a sustained level of nepafenac for six weeks. This is a prospective, randomised, parallel-arm, double-masked, placebo-controlled, phase II pilot...

Outcomes of augmented surgery for exotropia

This was a prospective study to assess patients with basic type intermittent exotropia of 15-45PD in angle and who were operated with augmented bilateral lateral rectus recessions with conjunctival recession, and followed postoperatively for six months. The study included 15...

Brolucizumab in age-related macular degeneration, HAWK Study

The aim of the study was to collect additional data on efficacy and safety of brolucizumab 6mg intended for commercialization in age-related macular degeneration (AMD) (with an increase in pH and decrease in polysorbate concentration). The HAWK Study was a...

What's trending Feb/Mar 2024

A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #ScleralTattoo #BlackEye Scleral tattoos aren’t necessarily a new phenomenon. A quick google search will identify cases being in the news from...

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...